We are live on
!
Find out more
NTC
North Tide Capital Portfolio holdings
AUM
$469M
1-Year Est. Return
6.57%
This Fund
S&P 500
This Quarter
Est. Return
+12.26%
1 Year Est. Return
+6.57%
3 Year Est. Return
+14.81%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.49B
AUM Growth
+$175M
(+13%)
Cap. Flow
+$37.1M
Cap. Flow
% of AUM
2.5%
Top 10 Holdings %
Top 10 Hldgs %
67.93%
Holding
27
New
2
Increased
7
Reduced
2
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$55.7M |
| 2 |
KND
Kindred Healthcare
KND
|
+$34.6M |
| 3 |
Quest Diagnostics
DGX
|
+$31.6M |
| 4 |
SVU
SUPERVALU Inc.
SVU
|
+$31.2M |
| 5 |
MGLN
Magellan Health Services, Inc.
MGLN
|
+$11.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$76.6M |
| 2 |
AbbVie
ABBV
|
+$63M |
| 3 |
WW
WW International
WW
|
+$8.06M |
| 4 |
NUVA
NuVasive, Inc.
NUVA
|
+$4.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 80.37% |
| 2 | Consumer Discretionary | 4.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Edwards Lifesciences
EW
$47.8B
| – | – |
-4,500,000
| Closed | -$76.6M |
|
|
NUVA
27
DELISTED
NuVasive, Inc.
NUVA
| – | – |
-115,000
| Closed | -$4.01M |
|
Similar funds
SD
DG
NBC
JWM
JPCCM
MCL
GIIO
FC
North Tide Capital's Q4 2014 Portfolio in Review
As of Q4 2014, North Tide Capital held 27 positions worth $1.49B, up 13% from $1.31B the previous quarter. Its ten largest holdings account for 68% of the portfolio.
North Tide Capital's Q4 2014 filing shows 2 new, 7 increased, 2 reduced and 2 closed positions. Its largest new stake was Rite Aid Corporation: 100,000 shares worth $15M. The largest sale was Edwards Lifesciences, an estimated $76.6M.
By sector, the portfolio is most concentrated in Healthcare at 80% of assets, down from 82% a quarter earlier, followed by Consumer Discretionary.
- North Tide Capital's largest Q4 2014 buy was Rite Aid Corporation: 100,000 shares worth $15M.
- North Tide Capital added most to Teva Pharmaceuticals in Q4 2014, an estimated $55.7M increase.
- North Tide Capital's biggest Q4 2014 reduction was AbbVie, cutting an estimated $63M.
- North Tide Capital fully exited Edwards Lifesciences in Q4 2014, selling an estimated $76.6M.
- North Tide Capital's ten largest holdings make up 68% of its $1.49B portfolio in Q4 2014.
- North Tide Capital opened 2 new positions and closed 2 in Q4 2014.
- North Tide Capital's portfolio value rose 13% quarter-over-quarter to $1.49B.
Based on North Tide Capital's 13F filing for Q4 2014, filed 13 Feb 2015.